PAVmed Inc Stock News

Goldman Sachs Group Inc. raised its holdings in PAVmed Inc. (NASDAQ:PAVM) by 19.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 71,226 shares of the companys stock after purchasing an additional 11,804 shares during the period. Goldman Sachs Group Inc.s holdings in PAVmed []

In last trading session, PAVmed Inc. (NASDAQ:PAVM) saw 2.56 million shares changing hands with its beta currently measuring 0.04. Companys recent per share price level of $3.34 trading at -$0.33 or -8.99% at ring of the bell on the day assigns it a market valuation of $276.45M. That closing price of PAVMs stock is at How To Know If PAVmed Inc. (NASDAQ:PAVM) Is Expensive At $3.34. Read More »

RFG Advisory LLC lifted its holdings in shares of PAVmed Inc. (NASDAQ:PAVM) by 99.0% during the 3rd quarter, Holdings Channel reports. The firm owned 177,050 shares of the companys stock after purchasing an additional 88,100 shares during the period. RFG Advisory LLCs holdings in PAVmed were worth $1,512,000 as of its most recent filing with []

Marshall Wace LLP reduced its stake in shares of PAVmed Inc. (NASDAQ:PAVM) by 74.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,593 shares of the companys stock after selling 153,284 shares during the quarter. Marshall Wace LLP owned approximately []

Credit Suisse AG raised its position in PAVmed Inc. (NASDAQ:PAVM) by 361.6% in the 2nd quarter, Holdings Channel reports. The fund owned 61,417 shares of the companys stock after acquiring an additional 48,113 shares during the period. Credit Suisse AGs holdings in PAVmed were worth $393,000 as of its most recent filing with the SEC. []

Marshall Wace North America L.P. lowered its position in shares of PAVmed Inc. (NASDAQ:PAVM) by 71.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 181,401 shares of the companys stock after selling 443,700 shares during the quarter. Marshall Wace North America L.P.s []

The stock price of PAVmed Inc (NASDAQ: PAVM) fell by over 10% pre-market today. This is why it happened.

PAVmed Inc. (PAVM) CEO Lishan Aklog on Q3 2021 Results - Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)---- $LUCD--PAVmed and Lucid provide business update and preliminary third quarter 2021 financial results.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis Treatment Candidate Keza

JPMorgan Chase & Co. boosted its holdings in PAVmed Inc. (NASDAQ:PAVM) by 18.3% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,698 shares of the companys stock after acquiring an additional 4,290 shares during the quarter. JPMorgan Chase & Co.s holdings in PAVmed []